HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Patrick W. Serruys Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Piazza, N. Articles by Serruys, P. W. Search for Related Content PubMed PubMed Citation Articles by Piazza, N. Articles by Serruys, P. W. Related Collections Valve disease Related Article

---

Editorials

Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions—Need for a Reappraisal?

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands

^_* Address correspondence to Dr Serruys, Department of Cardiology, Erasmus Medical Center, Thoraxcenter, Ba583a, Erasmus MC, 's-Gravendijkwal 230, Rotterdam, 3015 CE, the Netherlands (Email: p.w.j.c.serruys@erasmusmc.nl).

The published guidelines by Akins and colleagues for reporting mortality and morbidity after cardiac valvar intervention represent an important update since they were last published in 1996 [1]. Novel techniques and methods to treat valvar heart disease have emerged recently, in particular, transcatheter valve therapies. The updated guidelines are intended to apply "uniformly" to conventional open operation, minimally invasive (video-assisted or robotic) surgical procedures, and transcatheter valve therapies. The Councils of the American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The European Association for Cardio-Thoracic Surgery decided upon an Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. The authors of the guidelines are key experts in the field of cardiac surgery.

According to the authors, the guidelines are to facilitate the analysis and reporting of clinical studies of various therapeutic approaches to valvar heart disease such that meaningful comparisons can be made and inferences drawn from these studies. In its present context, the guidelines are limited to fulfill their intended purpose. The following points require further discussion: (1) refinement of the definitions of heart valve morbidity, (2) an extension of the list of outcome measures, including outcome measures particular to each therapeutic approach, (3) consideration to the reporting of device-oriented and patient-oriented composite end points, and (4) the implications of applying these guidelines . . . [Full Text of this Article]

Related Article

Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions—Need for a Reappraisal? (Response)

Cary W. Akins, Eugene H. Blackstone, D. Craig Miller, Nicholas T. Kouchoukos, and Marko I. Turina
Ann. Thorac. Surg. 2009 87: 359-360. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				J. Nloga, R. Henaine, M. Vergnat, F. Wautot, O. Desebbe, J. Robin, J. Ninet, and J. F. Obadia Mitral valve surgery in octogenarians: should we fight for repair? A survival and quality-of-life assessment Eur J Cardiothorac Surg, June 1, 2011; 39(6): 875 - 880. [Abstract] [Full Text] [PDF]

				M. B. Leon, N. Piazza, E. Nikolsky, E. H. Blackstone, D. E. Cutlip, A. P. Kappetein, M. W. Krucoff, M. Mack, R. Mehran, C. Miller, et al. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials: A Consensus Report From the Valve Academic Research Consortium J. Am. Coll. Cardiol., January 18, 2011; 57(3): 253 - 269. [Abstract] [Full Text] [PDF]

				M. B. Leon, N. Piazza, E. Nikolsky, E. H. Blackstone, D. E. Cutlip, A. P. Kappetein, M. W. Krucoff, M. Mack, R. Mehran, C. Miller, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium Eur. Heart J., January 6, 2011; (2011) ehq406v2. [Abstract] [Full Text] [PDF]

				N. Piazza, N. van Mieghem, A. Tzikas, R. Lange, P. de Jaegere, and P. W. Serruys Interpreting the current data on transcatheter aortic valve implantation: a difficult task Eur. Heart J. Suppl., September 1, 2010; 12(suppl_E): E41 - E45. [Full Text] [PDF]

				J. A. Sarralde, J. M. Bernal, J. Llorca, A. Ponton, L. Diez-Solorzano, J. R. Gimenez-Rico, and J. M. Revuelta Repair of Rheumatic Tricuspid Valve Disease: Predictors of Very Long-Term Mortality and Reoperation Ann. Thorac. Surg., August 1, 2010; 90(2): 503 - 508. [Abstract] [Full Text] [PDF]

				L. H. Edmunds Jr Editor's Note. Ann. Thorac. Surg., February 1, 2009; 87(2): 360 - 360. [Full Text] [PDF]